The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...
The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...
Celebrities have sent prostate cancer’s public profile soaring in recent years. But with accusations that some men are being ...
21hon MSN
Winnipeg man surpasses $25K fundraising goal for prostate cancer treatment not covered by province
A retired Winnipeg teacher who raised money for his own prostate cancer treatment after learning that provincial health ...
Dr. Ali Kasraeian from Kasraeian Urology is the first in our area to utilize a new minimally invasive treatment, called Focal Therapy, that precisely targets and destroys prostate cancer tumors.
The average age of men who get diagnosed is 67.
Early tests of the immunotherapy, which harnesses the body's immune system to fight cancer, saw the disease lessen in nearly half of men.
A drug for advanced prostate cancer has shown "remarkable" results in an early-stage trial, experts have said.
A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...
Irish and American researchers have identified a potential new way to counter treatment‑resistant prostate cancer by ...
A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...
MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results